Crinetics Pharmaceuticals, Inc. (CRNX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$37.75
Day's range
$39.25

Crinetics Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 15.76 M $572.40 M   10.26% 16.76%
BLACKROCK, INC. 05/13/2026 8.48 M $307.95 M   6.14% 9.01%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 8.34 M $302.84 M   20.27% 8.86%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 8.16 M $296.27 M   1.48% 8.67%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 6.40 M $232.30 M   0.13% 6.80%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 5.36 M $194.51 M   2.51% 5.69%
05/15/2026 4.67 M $169.76 M   100.00% 4.97%
05/08/2026 4.64 M $168.47 M   100.00% 4.93%
JANUS HENDERSON GROUP PLC 05/18/2026 4.52 M $164.23 M   1.79% 4.81%
ECOR1 CAPITAL, LLC 05/15/2026 4.29 M $155.74 M   0.00% 4.56%
BELLEVUE GROUP AG 05/15/2026 3.28 M $119.13 M   81,088.12% 3.49%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.48 M $90.12 M   10.62% 2.64%
STATE STREET CORP 05/15/2026 2.40 M $87.28 M   11.18% 2.55%
BAKER BROS. ADVISORS LP 05/15/2026 2.35 M $85.41 M   42.61% 2.50%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 1.94 M $70.48 M   3,182.46% 2.06%
SIREN, L.L.C. 05/14/2026 1.90 M $69.14 M   26.27% 2.02%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 1.88 M $68.20 M   20.76% 2.00%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2026 1.72 M $62.34 M   29.31% 1.82%
GW&K INVESTMENT MANAGEMENT, LLC 05/13/2026 1.62 M $58.79 M   9.64% 1.72%
NOVO HOLDINGS A/S 05/15/2026 1.55 M $56.30 M   -4.62% 1.65%
RTW INVESTMENTS, LP 05/15/2026 1.45 M $52.71 M   7.40% 1.54%
JPMORGAN CHASE & CO 05/13/2026 1.32 M $45.40 M   14.72% 1.41%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 1.14 M $41.38 M   268.28% 1.21%
FIRST LIGHT ASSET MANAGEMENT, LLC 05/15/2026 1.09 M $39.58 M   -8.76% 1.16%
AMERICAN CENTURY COMPANIES INC 05/15/2026 1.05 M $38.24 M   -1.50% 1.12%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 1.04 M $37.91 M   100.00% 1.11%
ORBIMED ADVISORS LLC 05/15/2026 999.00 K $36.28 M   0.00% 1.06%
MORGAN STANLEY 05/15/2026 919.69 K $33.40 M   19.62% 0.98%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 907.41 K $32.96 M   1.12% 0.96%
JENNISON ASSOCIATES LLC 05/06/2026 904.67 K $32.86 M   -29.41% 0.96%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 852.26 K $30.94 M   55.24% 0.91%
NORTHERN TRUST CORP 05/14/2026 841.30 K $30.56 M   9.29% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 833.42 K $30.27 M   6.58% 0.89%
CANDRIAM S.C.A. 04/30/2026 830.96 K $30.18 M   0.00% 0.88%
ABRDN PLC 04/29/2026 820.40 K $29.80 M   21.62% 0.87%
AMERIPRISE FINANCIAL INC 05/15/2026 798.33 K $29.00 M   32.79% 0.85%
FISHER ASSET MANAGEMENT, LLC 05/05/2026 762.70 K $27.70 M   0.53% 0.81%
BANK OF AMERICA CORP /DE/ 05/18/2026 716.13 K $26.01 M   -10.63% 0.76%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 708.47 K $25.73 M   100.00% 0.75%
MARSHALL WACE, LLP 05/15/2026 684.11 K $24.85 M   100.00% 0.73%
GOLDMAN SACHS GROUP INC 05/15/2026 628.16 K $22.81 M   10.76% 0.67%
FIERA CAPITAL CORP 05/12/2026 589.65 K $21.42 M   1.94% 0.63%
UBS GROUP AG 05/05/2026 571.90 K $20.77 M   -37.03% 0.61%
NUVEEN, LLC 04/30/2026 551.46 K $20.03 M   5.55% 0.59%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 05/11/2026 425.62 K $15.46 M   4.24% 0.45%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/14/2026 382.36 K $13.10 M   104.00% 0.41%
BANK OF NEW YORK MELLON CORP 05/05/2026 358.72 K $13.03 M   -11.43% 0.38%
PROSIGHT MANAGEMENT, LP 05/15/2026 350.00 K $12.71 M   33.13% 0.37%
IMPAX ASSET MANAGEMENT GROUP PLC 05/12/2026 350.00 K $12.71 M   27.27% 0.37%
BRAUN STACEY ASSOCIATES INC 04/22/2026 324.81 K $11.80 M   100.00% 0.35%

Crinetics Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 315 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals Inc. The most heavily invested institutionals were:

FMR LLC: 15.76 M

BlackRock, Inc.: 8.48 M

FARALLON CAPITAL MANAGEMENT LLC: 8.34 M

WELLINGTON MANAGEMENT GROUP LLP: 8.16 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 6.4 M

PRICE T ROWE ASSOCIATES INC /MD/: 5.36 M

130.53% of Crinetics Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 130.05 M shares in the last 24 months. This purchase volume represents approximately $4.97 B in transactions.